Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4
Mingfeng Yang, Ruike Yan, Ruohe Sha, Xinxin Wang, Sirui Zhou, Baifeng Li, Qianqian Zheng, Yanli Cao
Topics & Concepts
MedicineFatty liverPharmacologyDiseaseLipid metabolismSteatohepatitisInternal medicineEndocrinologyTea Polyphenols and EffectsSirtuins and Resveratrol in MedicineLiver Disease Diagnosis and Treatment